DK1830883T3 - Fremgangsmåde til at hæmme en nedgang i indlæring og/eller hukommelse hos dyr - Google Patents

Fremgangsmåde til at hæmme en nedgang i indlæring og/eller hukommelse hos dyr

Info

Publication number
DK1830883T3
DK1830883T3 DK05855706.7T DK05855706T DK1830883T3 DK 1830883 T3 DK1830883 T3 DK 1830883T3 DK 05855706 T DK05855706 T DK 05855706T DK 1830883 T3 DK1830883 T3 DK 1830883T3
Authority
DK
Denmark
Prior art keywords
learning
animals
definition
influence
procedure
Prior art date
Application number
DK05855706.7T
Other languages
English (en)
Inventor
Steven Curtis Zicker
Karen Joy Wedekind
Original Assignee
Hills Pet Nutrition Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hills Pet Nutrition Inc filed Critical Hills Pet Nutrition Inc
Application granted granted Critical
Publication of DK1830883T3 publication Critical patent/DK1830883T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/105—Aliphatic or alicyclic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/116—Heterocyclic compounds
    • A23K20/121—Heterocyclic compounds containing oxygen or sulfur as hetero atom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/174—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P60/00—Technologies relating to agriculture, livestock or agroalimentary industries
    • Y02P60/80—Food processing, e.g. use of renewable energies or variable speed drives in handling, conveying or stacking
    • Y02P60/87—Re-use of by-products of food processing for fodder production

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Psychiatry (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Feed For Specific Animals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK05855706.7T 2004-12-29 2005-12-29 Fremgangsmåde til at hæmme en nedgang i indlæring og/eller hukommelse hos dyr DK1830883T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US63992804P 2004-12-29 2004-12-29
US66909705P 2005-04-07 2005-04-07
PCT/US2005/047192 WO2006071919A2 (en) 2004-12-29 2005-12-29 Methods for inhibiting a decline in learning and/or memory in animals

Publications (1)

Publication Number Publication Date
DK1830883T3 true DK1830883T3 (da) 2013-11-25

Family

ID=36615500

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05855706.7T DK1830883T3 (da) 2004-12-29 2005-12-29 Fremgangsmåde til at hæmme en nedgang i indlæring og/eller hukommelse hos dyr

Country Status (12)

Country Link
US (1) US8535708B2 (da)
EP (1) EP1830883B1 (da)
JP (2) JP2008525528A (da)
CN (1) CN104304671A (da)
AU (1) AU2005322015B2 (da)
BR (1) BRPI0519642A8 (da)
CA (1) CA2592389C (da)
DK (1) DK1830883T3 (da)
ES (1) ES2436181T3 (da)
RU (1) RU2354136C1 (da)
WO (1) WO2006071919A2 (da)
ZA (2) ZA200705197B (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090156658A1 (en) * 2000-10-31 2009-06-18 Hill's Pet Nutrition, Inc. Antioxidant-Containing Food Composition For Use In Inhibiting Histamine Pathways In Companion Animals
US20020076470A1 (en) 2000-10-31 2002-06-20 Colgate-Palmolive Company Composition and method
CA2588709C (en) * 2004-11-24 2015-07-14 Hill's Pet Nutrition, Inc. Use of lipoic acid to improve hepatic clearance of xenobiotic substances
US20090176864A1 (en) * 2004-11-24 2009-07-09 Hill's Pet Nutrition, Inc. Methods For Improving Hepatic and Immune Function In An Animal
US8168161B2 (en) * 2004-12-22 2012-05-01 Hill's Pet Nutrition, Inc. Method to promote oral health in companion animals
CA2592844C (en) * 2004-12-30 2012-10-09 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
US8252742B2 (en) 2004-12-30 2012-08-28 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
BRPI0615211A2 (pt) * 2005-08-17 2013-01-15 Hills Pet Nutrition Inc composiÇço, mÉtodo para evitar ou tratar doenÇa renal ou para a melhora da funÇço renal, kit, e, meio para comunicar informaÇço sobre ou instruÇÕes para a mistura e administraÇço de um ou mais das composiÇÕes, componentes de composiÇço, composiÇÕes alimentÍcias, ingredientes alimentÍcios e medicamentos renais e para uso dos dispositivos de diagnàstico renal
EP2224930B1 (en) 2008-01-04 2016-06-15 Nestec S.A. Compositions comprising unsaturated fatty acids and nitric oxide releasing compounds and use thereof for enhancing congnitive and related functions
NO2384192T3 (da) * 2009-01-05 2018-03-24
DK2440065T3 (da) 2009-06-12 2018-12-10 Calanus As Copepodoliesammensætning, formuleringer, der omfatter oliesammensætningen, og anvendelse deraf til reduktion af ophobning af visceralt fedt, forbedring af glucosetolerance og forebyggelse eller behandling af fedmerelaterede sygdomme og forstyrrelser
CN105639121A (zh) * 2009-07-14 2016-06-08 希尔氏宠物营养品公司 包括持续释放的硫辛酸的宠物食品组合物及其制造和使用方法
EP2521460A4 (en) * 2010-01-06 2013-06-26 Nestec Sa DIETARY PLANS FOR IMPLEMENTING CALORIAL LIMITATIONS
JP5425325B2 (ja) * 2013-03-15 2014-02-26 株式会社秋田食肉卸センター 食肉の鮮度保持及びその加工肉の酸敗防止の方法及び飼料添加用組成物
EP3082445B1 (en) * 2013-12-18 2022-07-27 Spécialités Pet Food Palatability enhancers for pet food, method of preparation and uses thereof
BR112016028654A2 (pt) 2014-06-12 2018-07-10 Lonza Ag método para diminuição de dano muscular esquelético e / ou estresse oxidativo em mamíferos
US10888571B2 (en) 2015-12-18 2021-01-12 Lonza Consumer Health Inc. Method and composition for increasing muscle protein synthesis and/or functional strength in mammals
CN106138037A (zh) * 2016-08-24 2016-11-23 江苏农林职业技术学院 一种抗生物细胞氧化损伤的组合物及其应用
CN108783001A (zh) * 2018-06-28 2018-11-13 佛山市雷米高动物营养保健科技有限公司 具有抗氧化功能的宠物用营养颗粒及其制备方法和使用方法
CN109984251A (zh) * 2019-04-15 2019-07-09 喻洁 一种营养均衡的宠物狗粮及其制备方法

Family Cites Families (91)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4006266A (en) 1975-10-08 1977-02-01 The Quaker Oats Company Process for making a dry pet food having a hard component and a soft component
US4247562A (en) 1978-12-21 1981-01-27 The Quaker Oats Company Moist pet food with blood chunks and a fluid gravy system
US5006361A (en) 1980-10-03 1991-04-09 Cox James P Lipid pelletization methods, apparatus and products
US5030458A (en) 1989-11-27 1991-07-09 Shug Austin L Method for preventing diet-induced carnitine deficiency in domesticated dogs and cats
ES2043897T3 (es) 1988-01-28 1994-01-01 Koeltringer Peter Preparado de combinacion, en especial para el tratamiento de enfermedades de las celulas nerviosas.
JP2524217B2 (ja) 1988-04-18 1996-08-14 マルハ株式会社 脳機能改善組成物、学習能力増強剤、記憶力増強剤、痴呆予防剤または痴呆治療剤
US4883672A (en) 1988-04-29 1989-11-28 Shug Austin L Method for preventing diet induced carnitine deficiency in domesticated dogs and cats
IE904034A1 (en) 1989-11-09 1991-05-22 Asta Medica Ag A medicament containing r-ó-lipoic acid or s-ó-lipoic acid¹as active substance
US5419283A (en) 1992-04-08 1995-05-30 Ciuffo Gatto S.R.L. Animal chew toy of starch material and degradable ethylene copolymer
US5569670A (en) 1992-06-05 1996-10-29 Asta Medica Aktiengesellschaft Combination medications containing alpha-lipoic acid and related
US5292538A (en) 1992-07-22 1994-03-08 Metagenics, Inc. Improved sustained energy and anabolic composition and method of making
RU2071319C1 (ru) 1993-08-31 1997-01-10 Акционерное общество закрытого типа "Химбио" Способ улучшения процессов памяти
US5339771A (en) 1993-09-15 1994-08-23 Axelrod Herbert R Animal chew toy containing animal meal
US5894029A (en) 1994-03-21 1999-04-13 Purebred Pet Products, Inc. Method of making pet snack food
DE4427079C2 (de) * 1994-07-30 2002-12-19 Viatris Gmbh Verfahren zur Racemisierung von Enantiomeren der alpha-Liponsäure
US5599835A (en) 1994-11-23 1997-02-04 Fischer; Frederick B. Use of DL-lipoic acid as a medical food in the treatment of diabetes mellitus
RU2099078C1 (ru) 1994-12-08 1997-12-20 Акционерное общество закрытого типа "КОМКОН" Средство, обладающее антистрессовым, стресспротекторным, ноотропным, антиалкогольным и антинаркотическим действием, способы профилактики и лечения с его использованием
US5730988A (en) 1995-04-20 1998-03-24 Lynntech, Inc. Nutritional supplements for improving glucose metabolism
DE19630350C2 (de) 1996-07-26 1998-08-20 Siemens Ag Ultraschallwandler
JPH1042798A (ja) 1996-08-07 1998-02-17 Kagome Co Ltd リコピン含有飼料、並びにリコピン含有の畜肉または 卵
US5977162A (en) 1996-09-16 1999-11-02 Seidman; Michael D. Therapeutic treatment for auditory function
US6190591B1 (en) 1996-10-28 2001-02-20 General Mills, Inc. Embedding and encapsulation of controlled release particles
US5937790A (en) 1996-12-18 1999-08-17 Showa Denko Kabushiki Kaisha Anti-stress agent for animals and a method of reducing stress in animals
US5976568A (en) * 1997-02-21 1999-11-02 Medical Doctors' Research Institute, Inc. Modular system of dietary supplement compositions for optimizing health benefits and methods
IT1291113B1 (it) 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
US6232346B1 (en) 1997-03-27 2001-05-15 Michael J. Sole Composition for improvement of cellular nutrition and mitochondrial energetics
US6080788A (en) 1997-03-27 2000-06-27 Sole; Michael J. Composition for improvement of cellular nutrition and mitochondrial energetics
PT969744E (pt) 1997-03-27 2003-09-30 Michael J Sole Composicao nutritiva para melhorar a capacidade energetica celular
US5851573A (en) 1997-04-29 1998-12-22 The Iams Company Pet food composition for large breed puppies and method for promoting proper skeletal growth
US6346280B1 (en) 1997-05-15 2002-02-12 University Of Washington Composition and methods for inhibiting the formation of brain amyloid deposits
US5883083A (en) 1997-06-09 1999-03-16 Harlmen, Inc. Dietary supplement for alleviating behavioral problems in canines and reducing seizures in canines and felines
US5916912A (en) * 1997-06-16 1999-06-29 The Regents Of The University Of California Dietary composition for enhancing metabolism and alleviating oxidative stress
DE19726519A1 (de) 1997-06-23 1998-12-24 Asta Medica Ag Verfahren zur Herstellung trockener Thioctsäure
US6117477A (en) 1998-03-18 2000-09-12 Kal Kan Foods, Inc. Multicomponent food product and methods of making and using the same
DE19818563C2 (de) 1998-04-25 2003-04-17 Sueddeutsche Kalkstickstoff Verwendung von alpha-Liponsäure zur Verringerung des Appetits und/oder zur Körpergewichtsreduzierung
US6197340B1 (en) 1998-05-28 2001-03-06 Medical Research Institute Controlled release lipoic acid
IT1299191B1 (it) 1998-06-23 2000-02-29 Sigma Tau Healthscience Spa Composizione atta a prevenire e trattare l'osteoporosi e le alterazioni legate alla menopausa
ID28460A (id) 1998-07-08 2001-05-24 Lipogenics Inc Komposisi dan metoda untuk perlakuan dan pencegahan penyakit tulang dengan menggunakan tocotrienol
IT1302307B1 (it) 1998-09-01 2000-09-05 Sigma Tau Healthscience Spa Composizione ad attivita' antiossidante ed atta a migliorarel'utilizzazione metabolica del glucosio, comprendente acetil
CN1273030C (zh) 1998-10-16 2006-09-06 雀巢制品公司 缓慢消化的蛋白质及其用途
FR2786100B1 (fr) * 1998-11-24 2002-03-01 Aventis Laboratoire Nouvelle application therapeutique de la nicergoline
NZ527924A (en) 1999-01-29 2005-01-28 Mars Uk Ltd Antioxidant compositions and methods for companion animals
US6284786B1 (en) 1999-02-16 2001-09-04 The Center For The Improvement Of Human Functioning, Int'l., Inc. Treatment of cancer using lipoic acid in combination with ascorbic acid
US6238708B1 (en) 1999-02-23 2001-05-29 The Iams Company Composition and process for controlling glucose metabolism in companion animals by dietary starch
US6365211B1 (en) 1999-06-18 2002-04-02 The Procter & Gamble Co. Cooking aid with reduced foaming
EP1213971B1 (en) 1999-09-09 2011-06-15 Societe Des Produits Nestle S.A. Improving condition of elderly pets
WO2001021208A1 (en) 1999-09-23 2001-03-29 Juvenon Corporation Nutritional supplement for increased energy and stamina
CA2285490C (en) 1999-10-07 2003-11-18 Michael J. Sole Composition for improvement of cellular nutrition and mitochondrial energetics
US6426362B1 (en) * 1999-10-08 2002-07-30 Galileo Laboratories, Inc. Formulations of tocopherols and methods of making and using them
IL149421A0 (en) 1999-11-02 2002-11-10 Depomed Inc Pharmaceutical compositions containing fed mode inducing agents
WO2001032168A1 (en) * 1999-11-03 2001-05-10 Juvenon, Inc. Method of treating benign forgetfulness
US6379727B1 (en) 1999-12-29 2002-04-30 John F. Addy Flavoring system for pet foods
ES2239582T3 (es) 2000-01-20 2005-10-01 Innovet Italia S.R.L. Una composicion para tratar enfermedades articulares degenerativas.
US20030060503A1 (en) * 2000-01-25 2003-03-27 Juvenon, Inc. Nutritional supplements for mature pets
CA2399319A1 (en) 2000-01-25 2001-08-16 Nathan D. Hamilton Nutritional supplements for aged pets
KR20020090214A (ko) 2000-02-01 2002-11-30 머슬테크 리서치 앤드 디벨롭먼트, 인크. 근육을 키우거나 강도를 늘리기 위한 α리포산계의보조식품
US6669975B1 (en) 2000-02-03 2003-12-30 Mars Incorporated Customized dietary health maintenance system for pets
ATE439051T1 (de) 2000-04-14 2009-08-15 Mars Inc Zusammensetzungen und methoden zur verbesserung der vaskulären gesundheit
US20020076470A1 (en) 2000-10-31 2002-06-20 Colgate-Palmolive Company Composition and method
US20020076469A1 (en) * 2000-10-31 2002-06-20 Colgate-Palmolive Company Composition and method
US20020115710A1 (en) * 2000-10-31 2002-08-22 Zicker Steven Curtis Composition and method
IT1320180B1 (it) 2000-12-29 2003-11-26 Hunza Di Marazzita Maria Carme Preparazioni nutrizionali e terapeutiche dotate di attivita'antiossidante ed in grado di controllare gli eccessi ponderali e
EP1247456A3 (en) 2001-02-28 2003-12-10 Pfizer Products Inc. Palatable pharmaceutical compositions for companion animals
CA2439078C (en) 2001-03-09 2009-08-25 Societe Des Produits Nestle S.A. Composition improving age-related physiological deficits and increasing longevity
GB0119052D0 (en) 2001-08-03 2001-09-26 Mars Uk Ltd Foodstuff
JP2003052338A (ja) 2001-08-09 2003-02-25 Unitika Ltd 機能性卵及び養鶏用飼料
DE10151764A1 (de) 2001-10-19 2003-05-08 Basf Ag Kombination von Liponsäure und Glutamin in Lebens- und Arzneimitteln
US20030190343A1 (en) 2002-03-05 2003-10-09 Pfizer Inc. Palatable pharmaceutical compositions for companion animals
JP2003261456A (ja) 2002-03-08 2003-09-16 Howaizu:Kk 脳の老化予防剤
US6733793B2 (en) 2002-06-04 2004-05-11 Metaproteomics, Llc Oral composition with insulin-like activities and methods of use
US8841344B2 (en) 2002-10-03 2014-09-23 Hill's Pet Nutrition, Inc. Method of using omega-3 fatty acids
JP2007524402A (ja) 2003-07-03 2007-08-30 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド コンパニオン動物における精神活動の加齢劣化を減少させる組成物及び方法
TWI366442B (en) 2003-07-30 2012-06-21 Novartis Ag Palatable ductile chewable veterinary composition
US7078064B2 (en) 2003-12-03 2006-07-18 George Zabrecky Compositions and methods useful for treating and preventing chronic liver disease, chronic HCV infection and non-alcoholic steatohepatitis
US20070128310A1 (en) 2003-12-19 2007-06-07 Meni-One Co., Ltd. Astaxanthin-containing pet foods
ES2304585T3 (es) 2004-09-21 2008-10-16 Nestec S.A. Longevidad mejorada de gatos de avanzada edad.
US20090176864A1 (en) 2004-11-24 2009-07-09 Hill's Pet Nutrition, Inc. Methods For Improving Hepatic and Immune Function In An Animal
CA2588709C (en) 2004-11-24 2015-07-14 Hill's Pet Nutrition, Inc. Use of lipoic acid to improve hepatic clearance of xenobiotic substances
JP2006219467A (ja) 2005-02-10 2006-08-24 Oriza Yuka Kk 脂肪蓄積阻害剤
US8722112B2 (en) 2005-07-14 2014-05-13 Hill's Pet Nutrition, Inc. Method for prolonging the life of animals
JP2007062332A (ja) 2005-09-02 2007-03-15 Toyo Mach & Metal Co Ltd 射出成形機
JP4765491B2 (ja) 2005-09-02 2011-09-07 リコープリンティングシステムズ株式会社 インクジェット式記録ヘッドの駆動方法及びインクジェット式記録ヘッド並びに画像記録装置
DE102005057178A1 (de) 2005-11-30 2007-07-19 Basf Ag Verwendung von Zinksalzen der Liponsäure zur Behandlung von Fettstoffwechselstörungen
JP5119509B2 (ja) 2006-05-18 2013-01-16 ビーエイチエヌ株式会社 活動意欲向上剤
US20070292535A1 (en) 2006-06-19 2007-12-20 Tabbiner Philip S Strontium compositions and methods of treating arthritic and or osteoporitic conditions
JP2008063234A (ja) 2006-09-04 2008-03-21 Pharma Foods International Co Ltd 慢性腎不全予防・改善組成物
US7282225B1 (en) 2006-09-27 2007-10-16 Occular Technologies, Inc. Composition and methods for improving retinal health
JP5157007B2 (ja) 2007-05-11 2013-03-06 ビーエイチエヌ株式会社 骨強化剤
US20080299286A1 (en) 2007-06-04 2008-12-04 David B Josephson Palatability enhancing compositions and foods for pets, and methods regarding the same
US20080317725A1 (en) 2007-06-20 2008-12-25 Baum Seth J Compositions and methods of treating chronic kidney disease
AU2010204614B2 (en) 2009-01-16 2013-08-22 Hill's Pet Nutrition, Inc. Companion animal compositions including pyruvic acid and salts thereof and methods of use thereof

Also Published As

Publication number Publication date
AU2005322015B2 (en) 2010-02-25
US20090004299A1 (en) 2009-01-01
ZA201401388B (en) 2015-05-27
US8535708B2 (en) 2013-09-17
CA2592389A1 (en) 2006-07-06
JP2008525528A (ja) 2008-07-17
BRPI0519642A2 (pt) 2009-07-14
CN104304671A (zh) 2015-01-28
RU2007129001A (ru) 2009-02-10
WO2006071919A2 (en) 2006-07-06
EP1830883A2 (en) 2007-09-12
JP2012246292A (ja) 2012-12-13
BRPI0519642A8 (pt) 2017-10-03
ES2436181T3 (es) 2013-12-27
AU2005322015A1 (en) 2006-07-06
CA2592389C (en) 2013-05-14
EP1830883B1 (en) 2013-10-09
WO2006071919A3 (en) 2006-08-17
ZA200705197B (en) 2014-06-25
RU2354136C1 (ru) 2009-05-10
EP1830883A4 (en) 2008-03-05

Similar Documents

Publication Publication Date Title
DK1830883T3 (da) Fremgangsmåde til at hæmme en nedgang i indlæring og/eller hukommelse hos dyr
DK1969391T3 (da) Tyndfilm emitter-absorber indretning og fremgangsmåde
DK1984344T3 (da) Multicykliske aminosyrederivater og fremgangsmåder til anvendelse heraf
DK1738044T3 (da) Nöglekombinationseelement i nögleråemne og nögle
DK1753406T4 (da) Overtrukket tabletformulering og fremgangsmåde
DK1715893T3 (da) Direkte kompressionsformulering og fremgangsmåde
NO20053252L (no) Posipi - Kraft og signal i ror.
DE112005003865A5 (de) Grafikintegration in eine Prozesskonfigurations- und Steuerumgebung
DK1937276T3 (da) Forbedret testosterongel og fremgangsmåde til anvendelse deraf
DK1825209T3 (da) Instruktørledet træningsmiljø og brugerflader dermed
DK3144240T3 (da) Stabelbar pakning og fremgangsmåde til tilvejebringelse heraf
NO20042824L (no) System for merking og avlesing
DK1776181T3 (da) System og fremgangsmåde til fluidtilførsel
DK1979612T3 (da) Vindturbinesamling og relateret fremgangsmåde
DK1894567T3 (da) Ledsagende farmaceutiske midler og anvendelse deraf
DK1771421T3 (da) N-hydroxyamidderivater og anvendelse deraf
DK2029799T3 (da) Termostabile proteiner og fremgangsmåder til fremstilling og anvendelse heraf
NO2016020I2 (no) Imidacloprid og Flumetrin
IS8090A (is) Samsetning til að bæta vitsmuni og minni
NO20043977D0 (no) Fremgangsmate til lesing og deteksjonsinnretning
DK1819489T3 (da) Indretning og fremgangsmåde til portionering
DK1840121T3 (da) Glycinderivat og anvendelse heraf
NO20053880L (no) Fremgangsmate og anordning ved sementeringsventil
DK1869172T3 (da) Forgrenet aminosyre-aminotransferasegen og anvendelse deraf
FI20050738A (fi) RFID-lukulaitteisto ja -menetelmä